Gallacher Capital Management LLC Cassava Sciences Inc Transaction History
Gallacher Capital Management LLC
- $218 Billion
- Q3 2024
A detailed history of Gallacher Capital Management LLC transactions in Cassava Sciences Inc stock. As of the latest transaction made, Gallacher Capital Management LLC holds 23,400 shares of SAVA stock, worth $611,676. This represents 0.15% of its overall portfolio holdings.
Number of Shares
23,400
Previous 16,100
45.34%
Holding current value
$611,676
Previous $58.8 Million
471.09%
% of portfolio
0.15%
Previous 0.03%
Shares
8 transactions
Others Institutions Holding SAVA
# of Institutions
202Shares Held
14MCall Options Held
2.67MPut Options Held
6.01M-
Black Rock Inc. New York, NY3.22MShares$84.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.52MShares$65.9 Million0.0% of portfolio
-
State Street Corp Boston, MA1.16MShares$30.4 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.01MShares$26.4 Million0.0% of portfolio
-
Morgan Stanley New York, NY520KShares$13.6 Million0.0% of portfolio
About CASSAVA SCIENCES INC
- Ticker SAVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,097,900
- Market Cap $1.05B
- Description
- Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's...